SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-14-347300
Filing Date
2014-09-22
Accepted
2014-09-19 18:43:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d792799dsc13d.htm SC 13D 38805
  Complete submission text file 0001193125-14-347300.txt   40393
Mailing Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8
Business Address ADELAIDE CHAMBERS PETER STREET DUBLIN L2 8 011-353-1-649-8521
Horizon Pharma plc (Subject) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86365 | Film No.: 141112823
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 FRANK W. BURR BLVD, SUITE 5 TEANECK NJ 07666
Business Address 300 FRANK W. BURR BLVD, SUITE 5 TEANECK NJ 07666 (201) 836-2308
Vidara Therapeutics Holdings LLC (Filed by) CIK: 0001619143 (see all company filings)

IRS No.: 451285841 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D